Doctor CHEUNG Yin Ting

CUHK Employment

Assistant Professor, School of Pharmacy, Faculty of Medicine

Phone Number

+852 3943 6833


Yin Ting Cheung received her training on pharmacoepidemiology and cancer survivorship from the National University of Singapore (NUS) and St. Jude Children’s Research Hospital (Memphis, USA). Her work with the Cognitive Neuroscience Team at St. Jude involved characterizing the pharmacological, biological and genetic determinants of brain function and other treatment-related complications in survivors of childhood cancer.

Yin Ting joined the Faculty of Medicine at the Chinese University of Hong Kong in August 2017. She has initiated research/ commissioned projects for the Childhood Cancer Survivors’ Study (National Institute of Health, USA), the Chinese Children’s Cancer Group (CCCG), the Multinational Association for Supportive Care in Cancer (MASCC) and the Hospital Authority, as well as NGOs serving patients with cancer and hemophilia. She hopes that her collaborative research with students, clinicians and scientists can help to improve health outcomes in young survivors of cancer and other chronic diseases.


B.Sc.(Pharm) (Hons), Ph.D.

Research Interest

Major advances in health care delivery have dramatically improved survival rates for children, adolescents and young adults (AYAs) diagnosed with cancer and other life-threatening diseases. Unfortunately, survivorship often comes at a cost of developing a myriad of treatment-related complications that can have a negative impact on their functional outcomes and quality of life. Yin Ting’s research is focused on supportive care and survivorship in children and AYAs with cancer. Specifically, her research interests are:

  1. Investigating the physiological, biobehavioral, and pharmacological factors associated late effects, particularly adverse outcomes related to brain function, such as neurocognitive impairment, neurobehavioral problems, and psychological distress.
  2. Using real-world data to investigate drug utilization and subsequent health outcomes, as well as the effectiveness and safety of the use of complementary medicines in patients with cancer.
  3. Developing educational resources to engage children and AYAs in taking ownership of their health.



Supportive care and cancer survivorship

Integrative oncology

Awards and Honours

  1. The Barrie Cassilieth Memorial New Investigator Scholarship (Awarded to PhD. student Mr Jason Lam), Society for Integrative Oncology (SIO) Annual Meeting 2022
  2. Best Poster Award (Palliative and Supportive Care Category), European Society for Medical Oncology (ESMO)- Asia Congress 2022
  3. Silver Medal (Allied Health/Nurses Oral Abstracts Category), Joint Annual Scientific Meeting 2022 (Hybrid Meeting) of HKPS, HKCPaed, HKPNA, & HKCPN 2022
  4. Steven Grunberg Memorial Award (highest-ranking abstract; Role: Senior Author), Multinational Association for Supportive Care in Cancer (MASCC) Annual Meeting 2022
  5. Outstanding Trainee Award 2018/2019, Multinational Association for Supportive Care in Cancer (MASCC) Survivorship Study Group
  6. American Society of Clinical Oncology (ASCO) Meeting, Conquer Cancer Foundation Merit Award, 2013, 2015 and 2017


Professional Services/ Appointment (International)

  • Secretariat, Multinational Association of Supportive Care in Cancer (MASCC) Consumer Engagement Committee
  • Member, Children’s Oncology Group (COG) Long-term Follow-up Guidelines Committee, Neuropsychology Late Effects Panel
  • Member, Society for Integrative Oncology
  • Member, The International Society of Paediatric Oncology (SIOP)
  • External Member, Thesis Committee, Global Child Health Master’s Program, St Jude Children’s Research Hospital

Professional Services/ Appointment (Local)

  • Member and Deputy Chairman, Hospital Authority Central Institutional Review Board (Central IRB) –Pediatrics Panel
  • Member, Registration of Pharmaceutical Products & Substances: Certification of Clinical Trial/Medicinal Test Committee, Pharmacy & Poisons Board
  • Board Member, Little Life Warriors Society (NGO)
  • Member, Hong Kong Paediatric Haematology and Oncology Study Group (HKPHOSG)


  • Editorial Board Member of the Pediatric Blood & Cancer

Knowledge-transfer activities

  1. Speaker (Online Educational Series), Title: Personal Health Risks in Survivors of Childhood Cancer (3 episodes)【健康講講座系列】對「症」下藥,「知」多D、「做」好D (共三集).
  2. Speaker (Radio/Television Program), Title: Potential Interactions between Western and Chinese Medicines in Cancer Patients (兒童癌症康復者於服用長期藥物與補充或替代藥物之間的相互作用) RTHK 香港電台《精靈一點》, 23/11/2021.
  3. Press Release, Title: CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine (中大研究發現半數受訪兒童癌症康復者曾使用替代補充療法 或存在「藥療相互作用」風險)., 01/06/2021.
  4. Speaker (Television Program), Title: The Journey of Child Diagnosed with Cancer (孩子的抗癌路). NowTV《杏林在線》 (第242集), 01/01/2021.
  5. Speaker (Television Program), Title: The Safe Use of Medicine in Children (兒童藥物), NowTv 《杏林在線》 (第241集), 18/12/2021.

Researcher ID

Web of Science ID: AAT-4384-2021


Selected publications:

Survivorship and supportive care:

  1. van der Plas E, Modi A, Li CK, Cheung YT*. Cognitive Impairment in Survivors of Pediatric Acute Lymphoblastic Leukemia treated with Chemotherapy Only. Journal of Clinical Oncology. 2021;39(16):1705-1717.
  2. Cheung YT*, Ma CT, Lam HHW, Ling SC, Kwok K, Li CH, Ha CY, Yip SF, Wong RSM, Chu WCW, Li CK. Clinical, Neuroimaging, and Behavioral Risk Factors for Neurocognitive Impairment in Chinese Patients with Hemophilia: A Multicenter Study. Haemophila. 2023. Epub: 10.1111/hae.14816.
  3. Cheung YT*, Ma CT, Li MCH, Zhou KR, Loong HHF, Chan ASY, Wong KC, Li CK. Associations between Lifestyle Factors and Neurocognitive Impairment among Chinese Adolescent and Young Adult (AYA) Survivors of Sarcoma. Cancers. 2023;15(3):799.
  4. Ewig CLY, Hui KH, Lai SKL, Leung AWK, Wong GLH, Li CK, Cheung YT*. Medication Burden Among Pediatric Cancer Survivors: Analysis of a Population-Wide Electronic Database in Hong Kong. JNCI Cancer Spectrum. 2022;6(5):pkac059.
  5. Cheung YT*, Zhang H, Cai J, Au-Duong LWP, Yang LS, Yan C, Zhou F, Chen X, Guan X, Pui CH, Hudson MM, Li CK. Identifying Priorities for Harmonizing Guidelines for the Long-term Surveillance of Childhood Cancer Survivors in the Chinese Children Cancer Group (CCCG). JCO Global Oncology. 2021;7:261-276.
  6. Sato S, Li N, Dixon SB, Kato M, Zhang H, Li CK, Howell RM, Leisenring WM, Bhatia S, Oeffinger KC, Armstrong GT, Yasui Y, Krull KR, Cheung YT*. Functional Outcomes and Social Attainment in Asian/Pacific Islander Childhood Cancer Survivors in the United States: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiology Biomarkers & Prevention. 2021;30(12):2244-2255.
  7. Cheung YT*, Liu W, Leisenring W, Brinkman TM, Howell RM, Ullrich NJ, Lommel KM, Brouwers P, Gibson TM, Robison LL, Armstrong G, Krull KR. Prescription Psychoactive Medication Use in Adolescent Survivors of Childhood Cancer and Association with Adult Functional Outcome. JNCI Cancer Spectrum. 2020;4(5):pkaa057.
  8. Yan C, Cheung RS, Wong CL, Cheng HY, Liu F, Huang H, Ewig CL, Li CK, Zhang H, Cheung YT*. Stress and Perception of Procedural Pain Management in Chinese Parents of Children with Cancer. Journal of Pain and Symptom Management. 2020:S0885-3924(20)30571-6

Integrative oncology:

  1. Lam CS, Zhou K, Loong HH, Chung VC, Ngan CK, Cheung YT*. The Use of Traditional, Complementary, and Integrative Medicine in Cancer: Data-Mining Study of 1 Million Web-Based Posts From Health Forums and Social Media Platforms. Journal of Medical Internet Research. 2023;25:e45408.
  2. Lam CS, Ma CT, Li MCH, Wong CL, Loong HHF, Leung AWK, Li CK, Koon HK, Cheung YT. The Use of Traditional, Complementary and Integrative Medicine in Chinese Adolescent and Young Adult Patients with Cancer: A Multicenter Cross-sectional Study. European Journal of Oncology Nursing. 2023. Epub:
  3. Lam CS, Koon HK, Loong HH, Chung VC, Cheung YT*. Associations of Dietary Supplement Use with All-cause and Cause-specific Mortality in Patients Diagnosed with Cancer: A Large Prospective Cohort Study in the UK Biobank. European Journal of Nutrition. 2023;62(2):879-889.
  4. Lam CS, Koon HK, Chan CW, Lee TYH, Li RCH, Li CK, Man SS, Cheung YT*. The Use of Traditional, Complementary and Integrative Medicine in Chinese Paediatric Patients Receiving Palliative Care: A Multi-centre Study. BMJ Paediatrics Open. 2022;6(1):e001701
  5. Lam CS, Peng LW, Yang LS, Chou HWJ, Li CK, Zuo Z, Koon HK, Cheung YT*. Examining Patterns of Traditional Chinese Medicine Use in Pediatric Oncology: A Systematic Review, Meta-analysis and Data-mining Study. Journal of Integrative Medicine. 2022;S2095-4964(22)00069-3.
  6. Lam CS, Cheng YM, Li HS, Koon HK, Li CK, Ewig CLY*, Cheung YT*. Use of Complementary or Alternative Medicine and Potential Interactions with Chronic Medications among Chinese Survivors of Childhood Cancer. Journal of Cancer Survivorship. 2022;16(3):568-581

Health services programs:

  1. Wong ECY, Au-Doung PLW, Chu YYL, Wong SSY, Li CK, Cheung YT*. Psychological Distress and Social Support among Community Paediatric Palliative Care Programme Caregivers: Longitudinal Analysis. BMJ Supportive & Palliative Care. 2023:spcare-2023-004301.
  2. Ma CT, Chou HW, Lam TNN, Tung YT, Lai YW, Lee LK, Lee VWY, Yeung NCY, Leung AWK, Bhatia S, Li CK, Cheung YT*. Provision of a Personalized Survivorship Care Plan and its Impact on Cancer-related Health Literacy among Childhood Cancer Survivors in Hong Kong. Pediatric Blood & Cancer. 2023;70(2):e30084
  3. Cheung YT*, Yang LS, Ma CT, Woo PHK, Luk SMS, Chan TCH, Lee VWY, Yeung NCY, Li CK. Health Behaviour Practices and Expectations for a Local Cancer Survivorship Programme: A Cross-sectional Study of Survivors of Childhood Cancer in Hong Kong. Hong Kong Medical Journal. 2022;28(1):33-44
  4. Lam CS, Au KY, Hung HY, Chou HW, Leung AWK, Li CK, Koon HK*, Cheung YT*. Integrating Complementary Medicine Into the Care of Childhood Cancer Survivors: A Brief Report on the Preliminary Framework and Implementation of an Educational Program. Frontiers in Rehabilitation Science. 2022;3:897677.